CTAP TFA

• Target :

  Opioid Receptor

• Related Pathways :

  Endocrinology/Hormones|||GPCR/G Protein|||Neuroscience

• Bioactivity :

  CTAP TFA, a potent and highly selective ? opioid receptor antagonist that effectively crosses the blood-brain barrier, exhibits a significant inhibition concentration (IC50) of 3.5 nM. It demonstrates extraordinary selectivity, being over 1200-fold more specific to ? opioid receptors than to ? opioid (IC50 = 4500 nM) and somatostatin receptors. This compound is primarily leveraged for researching L-DOPA-induced dyskinesia (LID) and opiate overdose or addiction [1] [2].

• Molecular Formula :

  C53H70F3N13O12S2

• Molecular Weight :

  1218.32

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C